Jakob, Jens http://orcid.org/0000-0002-8499-7172
Lesluyes, Tom
Simeonova-Chergou, Anna
Wenz, Frederik
Hohenberger, Peter
Chibon, Frederic
Le Guellec, Sophie
Article History
Received: 11 September 2019
Accepted: 26 October 2019
First Online: 15 November 2019
Compliance with ethical guidelines
:
: J. Jakob and P. Hohenberger received research support and honoraria from Pfizer. P. Hohenberger acted as a consultant for Pfizer. T. Lesluyes, A. Simeonova-Chergou, F. Wenz, F. Chibon, and S. Le Guellec declare that they have no competing interests.
: The GISG 03 study was approved by the independent ethics committee II of the University of Heidelberg, Germany, and the German Federal Institute for Drugs and Medical Devices (BfArm). All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1975 Helsinki declaration and its later amendments. Informed consent was obtained from all indiviual participants included in the study.